Your browser doesn't support javascript.
loading
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial.
Nasser, Azmi; Liranso, Tesfaye; Adewole, Toyin; Fry, Nicholas; Hull, Joseph T; Chowdhry, Fatima; Busse, Gregory D; Melyan, Zare; Cutler, Andrew J; Findling, Robert L; Schwabe, Stefan.
Afiliação
  • Nasser A; Supernus Pharmaceuticals, Inc., Rockville, MD, USA. Electronic address: anasser@supernus.com.
  • Liranso T; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
  • Adewole T; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
  • Fry N; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
  • Hull JT; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
  • Chowdhry F; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
  • Busse GD; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
  • Melyan Z; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
  • Cutler AJ; SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA.
  • Findling RL; School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
  • Schwabe S; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
Clin Ther ; 43(4): 684-700, 2021 04.
Article em En | MEDLINE | ID: mdl-33750646
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Estimulantes do Sistema Nervoso Central Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Estimulantes do Sistema Nervoso Central Idioma: En Ano de publicação: 2021 Tipo de documento: Article